@FierceBiotech: With Roche in the rearview mirror, Constellation Pharma grabs $55M round. Article | Follow @FierceBiotech
@JohnCFierce: Now we get to see if Merck KGaA can swing big and actually hit the ball. Article | Follow @JohnCFierce
> Former GlaxoSmithKline ($GSK) CEO Jean-Pierre Garnier has taken the chairman spot at Alzheon, a startup developing a treatment for Alzheimer's disease. More
> Biogen ($BIIB) is looking into leasing a 350,000-square-foot space in Cambridge, MA's biotech hotbed of Kendall Square, the Boston Business Journal reports. News
> Canadian biotech upstart Inception IBD closed a $14.1 million Series A round to support its work on treatments for inflammatory bowel disease. Versant Ventures led the round, joined by Fonds de solidarité FTQ and Inserm Transfert Initiative. Release
Medical Device News
@FierceMedDev: ICYMI yesterday: Chemotherapy cooling cap to reduce hair loss for breast cancer patients gets FDA nod. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Edwards grabs option to acquire transcather mitral valve replacement startup. Article | Follow @VarunSaxena2
@EmilyWFierce: Cornell scientists create first litter of puppies through in vitro fertilization. FierceAnimalHealth story | Follow @EmilyWFierce
> Edwards ($EW) bets on treating degenerative regurgitation via mitral repair with Harpoon investment. More
> Bloomberg: Embattled Theranos CEO continues to beat the 'transparency' drum. Story
> MicroTransponder reels in $5.5M for stroke neurostimulation device. Article
Pharma News
@FiercePharma: India's Dr. Reddy's responds to U.S. FDA warning letter. FiercePharmaAsia article | Follow @FiercePharma
@CarlyHFierce: I'm sorry, but you had 20 years to brainstorm on this, and you came up with "Dengvaxia?" $SNY | Follow @CarlyHFierce
> FDA Commissioner to talk drug safety with top Chinese officials. More
> Sanofi ($SNY) gets first approval for long-anticipated vaccine against dengue fever. Story
> McCaskill raps 'Mr. Wu-Tang' Shkreli in Senate hearing over drug price hikes. Article
CRO News
> Icon ($ICLR) buys a trial site network with an eye on patient data. News
> WuXi ($WX) and PRA ($PRAH) break up their Chinese joint venture. More
> Charles River ($CRL) digs into Parkinson's R&D with Fox Foundation in tow. Story
> Quintiles ($Q) extends its R&D hand-holding service to biopharmas large and small. Report
> Restructured AMRI ($AMRI) cuts the ribbon on a drug discovery hub. Article
Pharma Manufacturing News
> Sucampo ($SCMP) finalizes $278M deal of R-Tech Ueno's manufacturing plant in Japan. News
> Axxess Pharma ($AXXE) has tapped SDC Nutrition for product manufacturing. Report
> FDA issues import alert on Pan Pharma, ramping up its pressure on the India drugmaker. Story
> Eli Lilly ($LLY) to manufacture human and animal drugs in separate facilities. Article
> Study: Shortfall of skilled inspectors in India hinders pharma industry. Item
Pharma Asia News
> WuXi and PRA Health amend ties in China. Item
> U.S. FDA files import alert on India's Pan Drugs. More
> China aims precision medicine plans at chronic diseases. Report
> Bangladesh again noted for dominant domestic drug manufacture. Story
> Takeda inks pact with Cour for celiac disease therapy via nanoparticles. Article